Your session is about to expire
← Back to Search
Exercise Program for Cancer (ACE Trial)
N/A
Recruiting
Led By Nicole Culos-Reed, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be over the age of 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to one-year
Awards & highlights
ACE Trial Summary
This trial will evaluate whether the Alberta Cancer Exercise Program, which helps cancer patients get active, improves their quality of life and prevents secondary cancers.
Who is the study for?
This trial is for adults over 18 with a cancer diagnosis who can do low-intensity exercise. It's open to those pre-treatment, currently receiving treatment, or up to 3 years post-treatment. Participants must be able to consent and understand English.Check my eligibility
What is being tested?
The study tests the Alberta Cancer Exercise (ACE) Program across clinics in Alberta. It aims to see if this community-based exercise program improves physical well-being and quality of life for cancer survivors and helps prevent secondary cancers.See study design
What are the potential side effects?
Since the intervention involves exercise, potential side effects may include typical risks associated with physical activity such as muscle soreness, fatigue, or injury; however these are generally mild and manageable.
ACE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18 years old.
ACE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to one-year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to one-year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physical Activity Minutes Per Week
Secondary outcome measures
Adverse events
Aerobic Endurance
Balance
+12 moreOther outcome measures
1RM or 8RM strength (optional)
Core endurance test (optional)
Home-based programming stepping test
+1 moreACE Trial Design
1Treatment groups
Experimental Treatment
Group I: Exercise InterventionExperimental Treatment1 Intervention
Participant exercise sessions will be conducted in groups of 10-15 under the direct supervision of the community-based exercise specialist. Sessions will be twice a week for 12-weeks. Participants will have the option to continue with the exercise program after the 12-weeks on a fee-for-service basis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760
Find a Location
Who is running the clinical trial?
Cross Cancer InstituteOTHER
61 Previous Clinical Trials
16,690 Total Patients Enrolled
Tom Baker Cancer CentreOTHER
29 Previous Clinical Trials
6,355 Total Patients Enrolled
University of AlbertaLead Sponsor
889 Previous Clinical Trials
382,634 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot safely do physical activities.I am over 18 years old.I have been diagnosed with cancer.I am currently undergoing cancer treatment, have had treatment in the last 3 years, or need supportive exercise due to cancer or its treatment.I can do light activities without much difficulty.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the aggregate enrolment rate of participants in this research?
"Affirmative. Based on the details available online through clinicaltrials.gov, this trial is actively recruiting participants as of July 26th 2022. The study first began to recruit patients in January 9th 2017 and requires 2500 individuals at two different locations to complete it successfully."
Answered by AI
Is enrollment into this research study still open?
"The clinical trial, which was uploaded to clinicaltrials.gov on January 9th 2017 and modified most recently on July 26th 2022, is presently recruiting participants for the study."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger